Role of Targeted Therapies in Advanced Cholangiocarcinoma

Saeed Sadeghi, MD, comments on the utilization of FGFR2 inhibitors as treatment for advanced cholangiocarcinoma.

EP. 1: Advanced Cholangiocarcinoma: Current Treatment Landscape

July 10th 2020

EP. 2: Driver Mutations in Advanced Cholangiocarcinoma

July 10th 2020

EP. 3: FGFR2 Inhibitors in Advanced Cholangiocarcinoma

July 10th 2020

EP. 4: Advanced Cholangiocarcinoma: FGFR2 Inhibitors vs Chemo

July 10th 2020

EP. 5: Optimizing Therapy for Advanced Cholangiocarcinoma

July 10th 2020